论文信息 - The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial. - 字舞流文

The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial.

M. Palmer | A. Wilson | M. Baum | I. Jackson | W. Whimster | L. Singh | I. H. Birch | C. Lowrey

[1] Analysis at Eight Years by 'Nolvadex',et al. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation. , 1988, British Journal of Cancer.

[2] B. Rasmussen,et al. BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES , 1985, The Lancet.

[3] Michael Baum,et al. IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER , 1983, The Lancet.

[4] M. Baum,et al. CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER Interim Analysis at Four Years by Nolvadex Adjuvant Trial Organisation , 1983, The Lancet.

[5] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[6] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[7] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[8] R. Blamey,et al. The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. , 1980, European journal of cancer.